<DOC>
	<DOCNO>NCT02598622</DOCNO>
	<brief_summary>The purpose study see drug call Acetyl-L-Carnitine help prevent painful nerve damage nerve pain cause vincristine , drug use chemotherapy child treat newly diagnose ALL . Acetyl-L-Carnitine drug available purchase nutritional supplement purpose study experimental .</brief_summary>
	<brief_title>A Pilot Study Investigating Effects Acetyl-L-Carnitine Vincristine-Induced Neuropathy Pediatric Patients With ALL</brief_title>
	<detailed_description />
	<mesh_term>Acetylcarnitine</mesh_term>
	<mesh_term>Vincristine</mesh_term>
	<criteria>Subjects must meet follow inclusion criterion . The subject must confirm diagnosis acute lymphoblastic leukemia within 1 week start therapy Currently treat standard ALL induction regimen Subjects must great equal 5 less 18 year old Signed informed consent Subjects exclude follow : Preexisting neurologic disease , include grade II , III , IV neurological status NCI Common Toxicity Criteria v3.0 clinical exam History hypersensitivity vincristine History hypersensitivity AcetylLcarnitine Previous use AcetylLcarnitine Concurrent anticonvulsant use Concurrent Gabapentin use Concurrent Glutamine use Liver Function : Total bilirubin great 1.3 mg/dL serum glutamicpyruvic transaminase ( SGPT ) ( ALT ) great 5 x upper limit normal age serum albumin less 2 g/dL Patients pregnant</criteria>
	<gender>All</gender>
	<minimum_age>5 Years</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>